Average Co-Inventor Count = 5.95
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (22 from 2,078 patents)
2. Astex Therapeutics Limited (3 from 123 patents)
3. Other (2 from 832,880 patents)
4. Tibotec Pharmaceuticals Ltd. (1 from 67 patents)
5. Janssen Pharmacatica, N.v. (1 from 1 patent)
29 patents:
1. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
2. 9464071 - Pyrazolyl quinoxaline kinase inhibitors
3. 8895601 - Pyrazolyl quinoxaline kinase inhibitors
4. 8377961 - Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53
5. 8232298 - Inhibitors of the interaction between MDM2 and P53
6. 8088795 - Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53
7. 7947695 - 5-membered annelated heterocyclic pyrimidines as kinase inhibitors
8. 7947694 - Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors
9. 7834016 - Inhibitors of the interaction between MDM2 and p53
10. 7407969 - Respiratory syncytial virus replication inhibitors
11. 7390811 - Respiratory syncytial virus replication inhibitors
12. 7378433 - N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
13. 7361657 - Respiratory syncytial virus replication inhibitors
14. 7355051 - Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
15. 7241763 - 3-furanyl analogs of toxoflavine as kinase inhibitors